Evaluation of magnesium as an adjuvant to ropivacaine-induced axillary brachial plexus block: A prospective, randomised, double-blind study

  title={Evaluation of magnesium as an adjuvant to ropivacaine-induced axillary brachial plexus block: A prospective, randomised, double-blind study},
  author={J. Deshpande and K. Patil},
  journal={Indian Journal of Anaesthesia},
  pages={310 - 315}
Background and Aims: Axillary brachial plexus block is commonly performed for surgeries on the hand and forearm. However, there are very few studies on the use of magnesium sulphate in axillary brachial plexus block and, hence, the study was designed to evaluate magnesium as an adjuvant to ropivacaine-induced axillary block with respect to onset and duration of sensorimotor block and postoperative analgesia. Methods: Sixty patients of the American Society of Anesthesiologists (ASA) physical… Expand
Ensuring practical feasibility and sustainability of research work: Need of the hour
The results of the study show significant reduction in low back pain with the help of a cost effective educational medium in the form of back care booklet as an intervention, along with usual pharmacological care in the clinical outpatient settings. Expand


Evaluation of Magnesium as an adjuvant in Ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded randomized controlled study
It can be concluded from this study that adding magnesium sulfate to supraclavicular brachial plexus block may increase the sensory and motor block duration and time to first analgesic use, and decrease total analgesic needs, with no side effects. Expand
Magnesium Added to Prilocaine Prolongs the Duration of Axillary Plexus Block
The admixture of magnesium to prilocaine for axillary brachial plexus block provided a pronounced prolongation of sensory and motor block without side effects. Expand
The Effects of Postoperative Brachial Plexus Block Using MgSO4 on the Postoperative Pain after Upper Extremity Surgery
Axillary brachial plexus block using MgSO4 did not reduce the level of postoperative pain and opioid consumption and there was no statistically significant difference in opioid consumption between the two groups. Expand
0.75% and 0.5% ropivacaine for axillary brachial plexus block: a clinical comparison with 0.5% bupivacaine.
It is concluded that 0.75% does not add benefit and 0.5% ropivacaine should be used to perform axillary brachial plexus blocks. Expand
A dose-finding randomised controlled trial of magnesium sulphate as an adjuvant in ultrasound-guided supraclavicular brachial plexus block
MgSO4 as adjuvant in brachial plexus block increases the duration of post-operative analgesia and in the dose of 250mg has greater efficacy as compared to 125 mg. Expand
Magnesium sulphate as an adjuvant to bupivacaine in ultrasound-guided transversus abdominis plane block in patients scheduled for total abdominal hysterectomy under subarachnoid block
MgSO4 (150 mg) as an adjuvant to bupivacaine in USG-guided TAP block reduces post-operative pain scores, prolongs the duration of analgesia and decreases demands for rescue analgesics. Expand
Adding magnesium to levobupivacaine for axillary brachial plexus block in arteriovenous fistule surgery.
By its decreasing effect on local anesthetic dose, magnesium may reduce the side effects due to high local anesthesia doses in patients with CRF and be able to be used for arteriovenous fistule surgery. Expand
Ultrasound guidance improves success rate of axillary brachial plexus block
This study demonstrates that ultrasound guidance, with or without concomitant nerve stimulation, significantly improves the success rate of axillary brachial plexus block. Expand
A study to observe the effects of addition of magnesium sulphate as an adjuvant to 0.5% bupivacaine for intrathecal anesthesia in surgeries of lower limbs
The effects of intrathecal Magnesium sulfate 100 mg, added to hyperbaric Bupivacaine 0.5% on the Spread, duration, regression of spinal block, and duration of postoperative analgesia in patients undergoing lower limb surgeries is investigated. Expand
A Clinical and Pharmacokinetic Comparison of Ropivacaine and Bupivacaine in Axillary Plexus Block
The clinical and pharmacokinetic properties of ropivacaine and bupivacaine, both 5 mg/mL, used in axillary plexus block were compared in 60 patients in this randomized, double-blind, parallel-groupExpand